• br Rationale Recently we have shown that the nasal CysLT

  2020-05-21

  

  Rationale Recently we have shown that the nasal CysLT2 receptor localized exclusively in blood vessels and the expression level of the CysLT2 receptor in patients with nasal allergy was higher than that in patients with non-allergic rhinitis (Shirasaki et al. Allergol Int 2013). We hypothesized t

• We found that both DDR and DDR ECD increased

  2020-05-20

  

  We found that both DDR1 and DDR2 ECD increased matrix mineralization as compared to native cells, with the effect of DDR2 ECD being more prominent. Both soluble (DDR2/ECD) and membrane-bound DDR2 ECD (DDR2/-KD), when compared to wild-type cells, induced larger mineral deposits. In this regard, a rec

• aromatase inhibitor br Acknowledgements This work was suppor

  2020-05-20

  

  Acknowledgements This work was supported by the European Committee Fifth Framework Project QLK5-1999-01360. We are grateful to Dr. T.T. Hoang for the provision of plasmids pEX18Tc, pPS858 and pFLP2, Prof. B.L. Wanner for providing us with the plasmid pKD4 and related strains, and Prof. P. Soucail

• br Conflict of interest br Acknowledgements This work was

  2020-05-20

  

  Conflict of interest Acknowledgements This work was funded by the National Science Centre, Poland, grant number N N303 571539. We are greatly indebted to Patrick Fox for help with the final manuscript. Introduction Alkylating agents which interact directly with DNA to form covalent bonds h

• In anticipation of an approach based on modification of the

  2020-05-20

  

  In anticipation of an approach based on modification of the cyclohexylacetic PMX 205 synthesis subunit of 1 as a means of improving permeability, a set of analogs were prepared to map out the optimum display of the acidic functionality. Homologated acids 25 and 26 were found to be equipotent to 1,

• br Role of cysLT signaling

  2020-05-20

  

  Role of cysLT signaling on various neurological complications which are associated with Alzheimer’s disease Alzheimer’s disease, first described in 1906 by Alois Alzheimer, is a neurodegenerative disease and a very common cause of dementia progressively leading to death. Even though years of rese

• Oxonic acid potassium salt Midazolam oral clearance is used

  2020-05-20

  

  Midazolam oral clearance is used for characterization of both intestinal and hepatic CYP3A activity. However, the identification and subsequent use of metabolic markers of CYP3A activity can eliminate the need for unnecessary administration of probe drugs such as midazolam. Such metabolic markers wo

• The following are the supplementary data related to this art

  2020-05-19

  

  The following are the supplementary data related to this article. Acknowledgments Introduction Cyclooxygenases metabolize arachidonic (+)-Aphidicolin to five primary prostanoids, PGE2, PGF2, PGI2, TXA2 (TX), and PGD2. These lipid mediators interact with specific members of a family of distin

• Ezetimibe receptor The following are the supplementary data

  2020-05-19

  

  The following are the supplementary data related to this article. Acknowledgments Introduction Cyclooxygenases metabolize arachidonic Ezetimibe receptor to five primary prostanoids, PGE2, PGF2, PGI2, TXA2 (TX), and PGD2. These lipid mediators interact with specific members of a family of dis

• br Introduction Epithelial mesenchymal transition EMT is a

  2020-05-19

  

  Introduction Epithelial-mesenchymal transition (EMT) is a biological process by which epithelial Rapalink-1 lose cell polarity and cell-cell adhesion, and gain mesenchymal features with an increase of migratory and invasive properties [1]. EMT is essential for mesoderm formation during embryo de

• Data on optimal hormone formulations routes of administratio

  2020-05-18

  

  Data on optimal hormone formulations, routes of administration, doses and duration of hormone use in young women with POF are lacking (Box 1). Transdermal SC 560 administration, which avoids the first-pass hepatic circulation and the increase in inflammatory markers such as C-reactive protein, while

• Previously we have reported that magnitude

  2020-05-18

  

  Previously, we have reported that magnitude of the disruption of the blood–aqueous barrier after paracentesis was reduced by 82% in EP4 receptor knockout mice (Biswas et al., 2006). In the present study, we observed that pretreatment of EP1 receptor knockout mice with EP4 receptor antagonist, reduce

• br STAR Methods br Acknowledgments We would

  2020-05-18

  

  STAR★Methods Acknowledgments We would like to thank Dr. Tsung-Ping and Dr. Shang-Yi Tsai, National Institute on Drug Abuse, NIH for sharing protocols on pulse chase experiments and analysis. We would like to thank Dr. William G. Telford for his valuable input on Amnis flow cytometry experiment

• To predict levels of SCF

  2020-05-18

  

  To predict levels of SCF assembly, Liu et al. (2018) first quantified the remaining necessary kinetic parameters and derived a model in combination with known functions and concentrations of components. The model agrees astonishingly well with many experimental observables. In terms of SCF assembly,

• Finally the identification of predictive biomarkers of respo

  2020-05-18

  

  Finally, the identification of predictive biomarkers of response will also allow the more recently discovered CDK inhibitors to be explored in particular genetically-defined contexts, for example by building on recent observations that KRAS mutant tumors are highly sensitive to CDK1 inhibition, and

15850 records 829/1057 page Previous Next First page 上5页 826827828829830 下5页 Last page